Women of Reproductive Age with Endometriosis are Not Osteopenic
article
OA: closed
CC0
⤵ 4 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper investigated bone mineral density in women of reproductive age with endometriosis and found no evidence of osteopenia.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (25)
- Bone Mineral Density of the Lumbar Spine in Endometriosis Subjects Compared to an Age-Similar Control Population* via openalex
- Endometriosis and anovulation: A coexisting problem in the infertile female via openalex
- Endometriosis: genetic and immunologic aspects. via openalex
- Identification of epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor in surgically induced endometriosis in rats. via openalex
- Immune dysfunction – a potential target for treatment in endometriosis via openalex
- Reduced Bone Mass in Reproductive-Aged Women with Endometriosis* via openalex
- Reduction of bone mineral density by gonadotropin‐releasing hormone agonist, nafarelin, is not completely reversible at 6 months after the cessation of administration via openalex
- Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment via openalex
- Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment. via openalex
- Total and regional bone mass values and biochemical markers of bone remodeling in endometriosis. via openalex
- Urinary N-Telopeptides to Monitor Bone Resorption While on GnRH Agonist Therapy via openalex
- W4290194174 via openalex
- W6625307131 via openalex
- W88676188 via openalex
- W6840866215 via openalex
- W2028712686 via openalex
- W2028874281 via openalex
- W2049589980 via openalex
- W2061958057 via openalex
- W2115660903 via openalex
- W2115941653 via openalex
- W2122437488 via openalex
- W2141986430 via openalex
- W2398742257 via openalex
- W2477008945 via openalex
Cited by (4)
- Bone mineral density in women with deep infiltrating endometriosis who have undergone early bilateral oophorectomy 2020
- Clinical Aspects of Endometriosis 2010
- Long-term fracture risk among women with proven endometriosis 2006
- The effects of a 3-month depot preparation of leuprorelin acetate on pain symptoms, bone mineral density and hormone levels in women with endometriosis—preliminary data analysis 2004
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:10:40.754221+00:00
License: CC0
· commercial use OK